Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension | Norton Healthcare

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Pulmonary Arterial Hypertension

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

Sub-indication: Pulmonary Arterial Hypertension

Study Type: Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: Sponsor: Gossamer Bio, Inc.

Learn more at ClinicalTrials.gov

Email for more information: npsresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Pulmonary Arterial Hypertension Clinical Trial

Schedule an Appointment